| Patents for C40B 30 - Methods of screening libraries (11,320) |
|---|
| 01/08/2013 | CA2462099C Compositions and methods for modeling saccharomyces cerevisiae metabolism |
| 01/03/2013 | WO2013000023A1 Method of protein display |
| 01/03/2013 | US20130007927 Novel centromeres and methods of using the same |
| 01/03/2013 | US20130007913 Biological systems input-output response system and plant sentinels |
| 01/03/2013 | US20130006342 Expression signature in peripheral blood for detection of aortic aneurysm |
| 01/03/2013 | US20130005837 Cancer biomarkers to predict recurrence and metastatic potential |
| 01/03/2013 | US20130005836 Composition and methods related to s100 a2 |
| 01/03/2013 | US20130005792 Biomarkers to identify hiv-specific t-cell subsets |
| 01/03/2013 | US20130005782 Method for integrin ligand discovery |
| 01/03/2013 | US20130005666 Reporter system for high throughput screening of compounds and uses thereof |
| 01/03/2013 | US20130005608 Yeast screens for treatment of human disease |
| 01/03/2013 | US20130005607 Quality control of agricultural products based on gene expression |
| 01/03/2013 | US20130005606 Packaged chip for multiplexing photonic crystal waveguide and photonic crystal slot waveguide devices for chip-integrated label-free detection and absorption spectroscopy with high throughput, sensitivity, and specificity |
| 01/03/2013 | US20130005605 Photonic Crystal MicroArray Layouts for Enhanced Sensitivity and Specificity of Label-Free Multiple Analyte Sensing, Biosensing and Diagnostic Assay |
| 01/03/2013 | US20130005604 Method for Label-Free Multiple Analyte Sensing, Biosensing and Diagnostic Assay |
| 01/03/2013 | US20130005603 Detecting nucleic acid |
| 01/03/2013 | US20130005602 Method for evaluating the sensitizing potential of a test compound |
| 01/03/2013 | US20130005601 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 01/03/2013 | US20130005600 Assay for Determining the Type and/or Status of a Cell Based on the Epigenetic Pattern and the Chromatin Structure |
| 01/03/2013 | US20130005599 Methods and systems of using exosomes for determining phenotypes |
| 01/03/2013 | US20130005598 Methods for Diagnosing The Malignant Potential of Pancreatic Cystic Lesions |
| 01/03/2013 | US20130005597 Methods and compositions for analysis of clear cell renal cell carcinoma (ccrcc) |
| 01/03/2013 | US20130005596 Novel genomic biomarkers for irritable bowel syndrome diagnosis |
| 01/03/2013 | US20130005595 Primer And Probe For Detection Of Mycobacterium Intracellulare, And Method For Detection Of Mycobacterium Intracellulare Using The Same |
| 01/03/2013 | US20130005594 Methods and compositions for detecting target nucleic acids |
| 01/03/2013 | US20130005593 RNA-Oligonucleotide Quantification Technique for the Enumeration of Uncultivated Bacterial Species |
| 01/03/2013 | US20130005592 Methods and compositions for predicting cancer therapy response |
| 01/03/2013 | US20130005591 Method for parallel amplification of nucleic acids |
| 01/03/2013 | US20130005590 Synthetic biology tools |
| 01/03/2013 | US20130005589 Highly sensitive method for detecting mutated gene |
| 01/03/2013 | US20130005588 Method for determining substance non-toxicity |
| 01/03/2013 | US20130005585 Nucleic acid encoding reactions |
| 01/03/2013 | US20130005581 Structural nucleic acid guided chemical synthesis |
| 01/03/2013 | US20130004528 Direct analysis of antigen-specific immune response |
| 01/03/2013 | US20130004513 Agents for treating disease |
| 01/03/2013 | US20130004509 BRAF Mutations Conferring Resistance to BRAF Inhibitors |
| 01/03/2013 | US20130004504 Method of modulating phenylalanine hydroxylase structure and function |
| 01/03/2013 | US20130004482 Methods of Treating Breast Cancer with Anthracycline Therapy |
| 01/03/2013 | US20130004473 Methods and Biomarkers for the Detection of Dengue Hemorrhagic Fever |
| 01/03/2013 | CA2840650A1 Method of protein display |
| 01/03/2013 | CA2840066A1 Signatures and determinants associated with prostate cancer progression and methods of use thereof |
| 01/02/2013 | EP2540389A1 Method of encapsulating a molecule and a microbead |
| 12/27/2012 | WO2012178128A1 Methods and compositions for the treatment and diagnosis of cancer |
| 12/27/2012 | WO2012141978A3 Formulations with reduced viscosity |
| 12/27/2012 | US20120331573 DYNACTIN SUBUNIT p62 BIOMARKER FOR NEUROLOGICAL CONDITIONS |
| 12/27/2012 | US20120329886 Use of periostin as a novel biomarker |
| 12/27/2012 | US20120329878 Phenotyping tumor-infiltrating leukocytes |
| 12/27/2012 | US20120329853 Microrna-based method for anti-colorectal cancer effects and prognosis of colorectal cancer |
| 12/27/2012 | US20120329676 High throughput screening method of acid-producing microorganism |
| 12/27/2012 | US20120329675 Testing of Biofilm for Anti-microbial Agent Susceptibility |
| 12/27/2012 | US20120329674 Methods for large scale functional evaluation of nucleotide sequences in plants |
| 12/27/2012 | US20120329673 Vectors and methods for selecting open reading frames |
| 12/27/2012 | US20120329672 MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma |
| 12/27/2012 | US20120329671 Methods of identifying obm modulators |
| 12/27/2012 | US20120329670 Epitope testing using soluble hla |
| 12/27/2012 | US20120329669 Use of dkk-1 protein in the cancer diagnosis |
| 12/27/2012 | US20120329668 Biomarkers for Determining an Allograft Tolerant Phenotype |
| 12/27/2012 | US20120329667 Epigenetic dna enrichment |
| 12/27/2012 | US20120329666 Peripheral Blood Biomarkers for Idiopathic Interstitial Pneumonia and Methods of Use |
| 12/27/2012 | US20120329665 Systems and methods for automated analysis of cells and tissues |
| 12/27/2012 | US20120329664 Multiplexed digital assays with combinatorial use of signals |
| 12/27/2012 | US20120329663 14-3-3 sigma as a Biomarker of Basal Cancer |
| 12/27/2012 | US20120329662 Hypoxia tumour markers |
| 12/27/2012 | US20120329067 Methods of Generating Zinc Finger Nucleases Having Altered Activity |
| 12/27/2012 | US20120328635 Chaperonin 10 variants |
| 12/27/2012 | US20120328629 Therapeutic Applications Targeting SARM1 |
| 12/27/2012 | US20120328628 Antibodies to conformationally trapped proteins |
| 12/27/2012 | US20120328620 Epidermalgrowth factor receptor mutations |
| 12/27/2012 | US20120328607 Genetic markers indicative of a cancer patient response to trastuzumab (herceptin) |
| 12/27/2012 | US20120328603 Assays and methods using biomarkers |
| 12/27/2012 | US20120328601 Modulation of Synaptic Maintenance |
| 12/27/2012 | US20120328594 Protein and lipid biomarkers providing consistent improvement to the prediction of type 2 diabetes |
| 12/27/2012 | US20120328590 Anti-cancer therapeutic strategy to overcome cancer resistance and to enable tailoring treatment to patients |
| 12/27/2012 | US20120328567 Biomarkers predictive of therapeutic responsiveness to ifnb and uses thereof |
| 12/27/2012 | CA2840946A1 Methods and compositions for the treatment and diagnosis of cancer |
| 12/27/2012 | CA2840472A1 Methods and compositions for the treatment and diagnosis of bladder cancer |
| 12/26/2012 | EP2536757A1 Fibronectin based scaffold domain proteins that bind il-23 |
| 12/26/2012 | CN102844443A Methods and compositions for the diagnosis and treatment of thyroid cancer |
| 12/25/2012 | US8338124 Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
| 12/25/2012 | US8336456 Printing in a medium |
| 12/23/2012 | CA2744508A1 Use of alpha-2-macroglobulin for determining osteonecrosis disease status and for screening therapeutic agents for treating osteonecrosis |
| 12/20/2012 | US20120322802 Novel 2, 4-pyrimidine derivatives and use thereof |
| 12/20/2012 | US20120322743 Compositions and Methods for Diagnosing and Treating Melanoma |
| 12/20/2012 | US20120322717 Compounds and assays for controlling Wnt activity |
| 12/20/2012 | US20120322689 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof |
| 12/20/2012 | US20120322688 Testing lumenectomy samples for markers of non-vascular diseases |
| 12/20/2012 | US20120322687 Methods of predicting high grade gliomas using senescence associated genes |
| 12/20/2012 | US20120322686 Methods for screening antibodies |
| 12/20/2012 | US20120322685 Device for collecting and analyzing migratory tumor cells |
| 12/20/2012 | US20120322684 G-csf protein having a deletion of an amino acid sequence corresponding to exon 3 for use as a diagnostic cancer marker |
| 12/20/2012 | US20120322683 Enzymatic signal generation and detection of binding complexes in stationary fluidic chip |
| 12/20/2012 | US20120322682 Brain injury biomarker panel |
| 12/20/2012 | US20120322681 Methods for Preparative In Vitro Cloning |
| 12/20/2012 | US20120322680 Use of mirnas as biomarkers in glioma diagnosis |
| 12/20/2012 | US20120322679 Biochemical analysis instrument |
| 12/20/2012 | US20120322678 Novel phage display vector |
| 12/20/2012 | US20120322677 Predicting benefit of anti-cancer therapy via array comparative genomic hybridization |
| 12/20/2012 | US20120322676 Compositions and methods for detection of cronobacter spp. and cronobacter species and strains |
| 12/20/2012 | US20120322675 Genome-scale analysis of replication timing |
| 12/20/2012 | US20120322674 Detecting cyp24 expression level as a marker for predisposition to cancer |